Revised SPC: Soliris (eculizumab) 300 mg concentrate for solution for infusion

Home infusion may now be considered for patients who have tolerated infusions in clinic. The decision of a patient to receive home infusions should be made after evaluation and recommendation by the treating physician and be performed by a qualified healthcare professional.


electronic Medicines compendium